Stockholders’ Equity (Tables)

9 Months Ended

Oct. 31, 2017

The following table summarizes the unvested shares granted on September 12, 2017, which have been made under the 2017 Plan.

	Number of shares awarded total
	Minimum		Target		Maximum		Cap
Employees		21,145		31,718		42,291		50,748
Non-Employee Directors		7,246		10,870		14,493		17,391
Total		28,391		42,588		56,784		68,139

	Value at grant date (numbers below are rounded to the nearest $100)
	Minimum		Target		Maximum		Cap
Employees	$	291,800	$	437,700	$	583,600	$	700,300
Non-Employee Directors		100,000		150,000		200,000		240,000
Total	$	391,800	$	587,700	$	783,600	$	940,300

The Company recognized total stock-based compensation costs

which are reflected in operating expenses:

	Three Months Ended October 31,				Nine Months Ended October 31,
	2017		2016		2017		2016
2012 Plan	$	—	$	392	$	206	$	(9,756)
2015 Plan		—		98,642		197,284		186,712
2017 Plan		93,981		—		93,981		—
Total stock-based compensation	$	93,981	$	99,034	$	291,471	$	176,966
Total income tax benefit recognized for stock-based compensation arrangements	$	33,833	$	35,652	$	104,929	$	63,708

Shares issued under 2017, 2015 and 2012 Stock Plans	Outstanding Unvested Grants at Maximum at Beginning of FY18		Granted during FY18 through October 31, 2017		Becoming Vested during FY18 through October 31, 2017		Forfeited during FY18 through October 31, 2017		Outstanding Unvested Grants at Maximum at End of October 31, 2017
Restricted stock grants – employees		67,619		42,291		40,570		27,049		42,291
Restricted stock grants – non-employee directors		—		14,493		—		—		14,493
Retainer in stock – non-employee directors		32,372		2,674		27,151		—		7,895
Total restricted stock		99,991		59,458		67,721		27,049		64,679

Weighted average grant date fair value	$	10.18	$	13.89	$	10.18	$	10.19	$	13.59